Call it cancer

Oncologist

Volumn 17, Issue 2, 2012, Pages 149-150

  Chabner, Bruce A ^a   Smith, Matthew ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BREAST CANCER; CANCER SCREENING; DEATH; DISEASE SURVEILLANCE; GLEASON SCORE; HUMAN; INCIDENCE; LIFE EXPECTANCY; MORBIDITY; MORTALITY; NOTE; PRIORITY JOURNAL; PROSTATE CANCER; SURVIVAL RATE;

FEMALE; HUMANS; MALE; NEOPLASMS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 84930482151     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2012-0004     Document Type: Note

References (6)

1. Melville H. Moby-Dick: or, The Whale. New York, NY: Penguin Classics, 2001.
2. Ganz PA, Barry JM, Burke W et al. National Institutes of Health State-of-the-Science Conference: Role of Active Surveillance in the Management of Men with Localized Prostate Cancer. Available at http://consensus.nih.gov/2011/docs/prostate/ASPCFinalDraftStatement.pdf, accessed December 11, 2011.
3. U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149:185-191.
4. Siegel R, Ward E, Brawley O et al. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212-236.
5. Schröder FH, Hugosson J, Roobol MJ et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009;360:1320-1328.
6. Andriole GL, Crawford ED, Grubb RL 3rd et al. Mortality results from a randomized prostate cancer screening trial. N Engl J Med. 2009;360:1310-1319. Erratum in: N Engl J Med 2009;360:1797.